No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 3.4x · 10Y median 1.9x · 83rd percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 25
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T19:08:33.762Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T19:08:33.762Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T19:08:33.762Z. Latest historical point 2025-05-16. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T19:08:33.762Z. Latest historical point 2025-02-14. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T19:08:33.762Z. Latest historical point 2022-09-28.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T19:08:33.762Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T19:08:33.762Z. Latest historical point 2025-05-16. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T19:08:33.762Z. Latest historical point 2025-02-14. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Upexi, Inc. (UPXI) stock was $1.15 as of Oct 6, 2026, 3:05 PM EDT, down 0.27% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -84.4% · 3-year avg -67.5%/yr · 5-year avg -58.8%/yr
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products.
Internet Content & Information · Tampa, FL
Next Earnings Date
Nov 11, 2026
36 days away
EPS Estimate
-0.23
Revenue Est.
$4.20M
Last Quarter Results
EPS
$-0.10
vs Estimate
$-0.11
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1UPXI | $84.24M | $1.15 | -0.27% | -84.40% | -58.80% | N/A | N/A |
| 2GLIBA | $87.29M | $23.91 | +1.27% | -37.02% | N/A | N/A | vs UPXI |
| 3FLNT | $80.20M | $2.69 | -5.28% | +24.43% | -26.59% | -20.26% | vs UPXI |
| 4MDIA | $79.99M | $1.04 | +0.97% | -18.18% | -33.85% | N/A | vs UPXI |
| 5GLIBK | $89.14M | $23.95 | +1.68% | -36.71% | N/A | N/A | vs UPXI |
| 6PODC | $68.85M | $2.28 | +0.44% | +38.20% | N/A | N/A | vs UPXI |
N/A
$3.15M
vs Estimate
$5.80M
Consensus Rating
Based on 1 analyst
Average Price Target
$2.00
+74.4% upside
Low
$2.00
Current
$1.15
High
$2.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.23 | $-0.23 | $-0.23 | 1 |
| Quarter ending Dec 2026 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Quarter ending Mar 2027 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Quarter ending Jun 2027 | $-0.10 | $-0.10 | $-0.10 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $-0.11 | $-0.11 | $-0.11 | 1 |
| FY 2028 | $0.02 | $0.02 | $0.02 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $4.20M | $4.20M | $4.20M | 1 |
| Quarter ending Dec 2026 | $5.60M | $5.60M | $5.60M | 1 |
| Quarter ending Mar 2027 | $7.40M | $7.40M | $7.40M | 1 |
| Quarter ending Jun 2027 | $9.50M | $9.50M | $9.50M | 1 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $26.70M | $26.70M | $26.70M | 1 |
| FY 2028 | $43.60M | $43.60M | $43.60M | 1 |
